302 related articles for article (PubMed ID: 18215770)
1. Determining the structure and mode of action of microbisporicin, a potent lantibiotic active against multiresistant pathogens.
Castiglione F; Lazzarini A; Carrano L; Corti E; Ciciliato I; Gastaldo L; Candiani P; Losi D; Marinelli F; Selva E; Parenti F
Chem Biol; 2008 Jan; 15(1):22-31. PubMed ID: 18215770
[TBL] [Abstract][Full Text] [Related]
2. A novel lantibiotic acting on bacterial cell wall synthesis produced by the uncommon actinomycete Planomonospora sp.
Castiglione F; Cavaletti L; Losi D; Lazzarini A; Carrano L; Feroggio M; Ciciliato I; Corti E; Candiani G; Marinelli F; Selva E
Biochemistry; 2007 May; 46(20):5884-95. PubMed ID: 17469849
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the congeners in the lantibiotic NAI-107 complex.
Maffioli SI; Iorio M; Sosio M; Monciardini P; Gaspari E; Donadio S
J Nat Prod; 2014 Jan; 77(1):79-84. PubMed ID: 24422756
[TBL] [Abstract][Full Text] [Related]
4. Strategies for the isolation and characterization of antibacterial lantibiotics.
Jabes D; Donadio S
Methods Mol Biol; 2010; 618():31-45. PubMed ID: 20094856
[TBL] [Abstract][Full Text] [Related]
5. Posttranslationally modified bacteriocins--the lantibiotics.
Guder A; Wiedemann I; Sahl HG
Biopolymers; 2000; 55(1):62-73. PubMed ID: 10931442
[TBL] [Abstract][Full Text] [Related]
6. Structure revision of the lantibiotic 97518.
Maffioli SI; Potenza D; Vasile F; De Matteo M; Sosio M; Marsiglia B; Rizzo V; Scolastico C; Donadio S
J Nat Prod; 2009 Apr; 72(4):605-7. PubMed ID: 19301921
[TBL] [Abstract][Full Text] [Related]
7. Brominated Variant of the Lantibiotic NAI-107 with Enhanced Antibacterial Potency.
Cruz JC; Iorio M; Monciardini P; Simone M; Brunati C; Gaspari E; Maffioli SI; Wellington E; Sosio M; Donadio S
J Nat Prod; 2015 Nov; 78(11):2642-7. PubMed ID: 26512731
[TBL] [Abstract][Full Text] [Related]
8. Isolation, structure elucidation, and synergistic antibacterial activity of a novel two-component lantibiotic lichenicidin from Bacillus licheniformis VK21.
Shenkarev ZO; Finkina EI; Nurmukhamedova EK; Balandin SV; Mineev KS; Nadezhdin KD; Yakimenko ZA; Tagaev AA; Temirov YV; Arseniev AS; Ovchinnikova TV
Biochemistry; 2010 Aug; 49(30):6462-72. PubMed ID: 20578714
[TBL] [Abstract][Full Text] [Related]
9. New developments in lantibiotic biosynthesis and mode of action.
Patton GC; van der Donk WA
Curr Opin Microbiol; 2005 Oct; 8(5):543-51. PubMed ID: 16118063
[TBL] [Abstract][Full Text] [Related]
10. Lantibiotics: diverse activities and unique modes of action.
Asaduzzaman SM; Sonomoto K
J Biosci Bioeng; 2009 May; 107(5):475-87. PubMed ID: 19393544
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of NAI-802, a new lantibiotic produced by two different Actinoplanes strains.
Simone M; Monciardini P; Gaspari E; Donadio S; Maffioli SI
J Antibiot (Tokyo); 2013 Feb; 66(2):73-8. PubMed ID: 23168402
[TBL] [Abstract][Full Text] [Related]
12. A Novel Microbisporicin Producer Identified by Early Dereplication during Lantibiotic Screening.
Carrano L; Abbondi M; Turconi P; Candiani G; Marinelli F
Biomed Res Int; 2015; 2015():419383. PubMed ID: 26346738
[TBL] [Abstract][Full Text] [Related]
13. The mode of action of the lantibiotic lacticin 3147--a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II.
Wiedemann I; Böttiger T; Bonelli RR; Wiese A; Hagge SO; Gutsmann T; Seydel U; Deegan L; Hill C; Ross P; Sahl HG
Mol Microbiol; 2006 Jul; 61(2):285-96. PubMed ID: 16771847
[TBL] [Abstract][Full Text] [Related]
14. Biosynthesis and mode of action of lantibiotics.
Chatterjee C; Paul M; Xie L; van der Donk WA
Chem Rev; 2005 Feb; 105(2):633-84. PubMed ID: 15700960
[No Abstract] [Full Text] [Related]
15. Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity.
Martin NI; Sprules T; Carpenter MR; Cotter PD; Hill C; Ross RP; Vederas JC
Biochemistry; 2004 Mar; 43(11):3049-56. PubMed ID: 15023056
[TBL] [Abstract][Full Text] [Related]
16. A system for the random mutagenesis of the two-peptide lantibiotic lacticin 3147: analysis of mutants producing reduced antibacterial activities.
Field D; Collins B; Cotter PD; Hill C; Ross RP
J Mol Microbiol Biotechnol; 2007; 13(4):226-34. PubMed ID: 17827973
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of a bioactive lantibiotic produced by Staphylococcus warneri.
Petersen J; Boysen A; Fogh L; Tabermann K; Kofoed T; King A; Schrotz-King P; Hansen MC
Biol Chem; 2009; 390(5-6):437-44. PubMed ID: 19361283
[TBL] [Abstract][Full Text] [Related]
18. Lantibiotics: promising candidates for future applications in health care.
Dischinger J; Basi Chipalu S; Bierbaum G
Int J Med Microbiol; 2014 Jan; 304(1):51-62. PubMed ID: 24210177
[TBL] [Abstract][Full Text] [Related]
19. Feed-forward regulation of microbisporicin biosynthesis in Microbispora corallina.
Foulston L; Bibb M
J Bacteriol; 2011 Jun; 193(12):3064-71. PubMed ID: 21478362
[TBL] [Abstract][Full Text] [Related]
20. Type AII lantibiotic bovicin HJ50 with a rare disulfide bond: structure, structure-activity relationships and mode of action.
Zhang J; Feng Y; Teng K; Lin Y; Gao Y; Wang J; Zhong J
Biochem J; 2014 Aug; 461(3):497-508. PubMed ID: 24814218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
